Cargando…

Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes

BACKGROUND: Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the development of stage ≥3 CKD has been less explored in type 1 diabetes mellitus...

Descripción completa

Detalles Bibliográficos
Autores principales: Mirijello, Antonio, Viazzi, Francesca, Fioretto, Paola, Giorda, Carlo, Ceriello, Antonio, Russo, Giuspina T., Guida, Pietro, Pontremoli, Roberto, De Cosmo, Salvatore
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280443/
https://www.ncbi.nlm.nih.gov/pubmed/30514308
http://dx.doi.org/10.1186/s12882-018-1136-6
_version_ 1783378673949212672
author Mirijello, Antonio
Viazzi, Francesca
Fioretto, Paola
Giorda, Carlo
Ceriello, Antonio
Russo, Giuspina T.
Guida, Pietro
Pontremoli, Roberto
De Cosmo, Salvatore
author_facet Mirijello, Antonio
Viazzi, Francesca
Fioretto, Paola
Giorda, Carlo
Ceriello, Antonio
Russo, Giuspina T.
Guida, Pietro
Pontremoli, Roberto
De Cosmo, Salvatore
author_sort Mirijello, Antonio
collection PubMed
description BACKGROUND: Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the development of stage ≥3 CKD has been less explored in type 1 diabetes mellitus (T1DM) patients. Aim of the present study was to evaluate the prognostic role of kidney disease measures, namely albuminuria and reduced GFR, on the development of stage ≥3 CKD in a large cohort of patients affected by T1DM. METHODS: A total of 4284 patients affected by T1DM followed-up at 76 diabetes centers participating to the Italian Association of Clinical Diabetologists (Associazione Medici Diabetologi, AMD) initiative constitutes the study population. Urinary albumin excretion (ACR) and estimated GFR (eGFR) were retrieved and analyzed. The incidence of stage ≥3 CKD (eGFR < 60 mL/min/1.73 m2) or eGFR reduction > 30% from baseline was evaluated. RESULTS: The mean estimated GFR was 98 ± 17 mL/min/1.73m(2) and the proportion of patients with albuminuria was 15.3% (n = 654) at baseline. About 8% (n = 337) of patients developed one of the two renal endpoints during the 4-year follow-up period. Age, albuminuria (micro or macro) and baseline eGFR < 90 ml/min/m(2) were independent risk factors for stage ≥3 CKD and renal function worsening. When compared to patients with eGFR > 90 ml/min/1.73m(2) and normoalbuminuria, those with albuminuria at baseline had a 1.69 greater risk of reaching stage 3 CKD, while patients with mild eGFR reduction (i.e. eGFR between 90 and 60 mL/min/1.73 m2) show a 3.81 greater risk that rose to 8.24 for those patients with albuminuria and mild eGFR reduction at baseline. CONCLUSIONS: Albuminuria and eGFR reduction represent independent risk factors for incident stage ≥3 CKD in T1DM patients. The simultaneous occurrence of reduced eGFR and albuminuria have a synergistic effect on renal function worsening. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-018-1136-6) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-6280443
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62804432018-12-10 Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes Mirijello, Antonio Viazzi, Francesca Fioretto, Paola Giorda, Carlo Ceriello, Antonio Russo, Giuspina T. Guida, Pietro Pontremoli, Roberto De Cosmo, Salvatore BMC Nephrol Research Article BACKGROUND: Albuminuria has been classically considered a marker of kidney damage progression in diabetic patients and it is routinely assessed to monitor kidney function. However, the role of a mild GFR reduction on the development of stage ≥3 CKD has been less explored in type 1 diabetes mellitus (T1DM) patients. Aim of the present study was to evaluate the prognostic role of kidney disease measures, namely albuminuria and reduced GFR, on the development of stage ≥3 CKD in a large cohort of patients affected by T1DM. METHODS: A total of 4284 patients affected by T1DM followed-up at 76 diabetes centers participating to the Italian Association of Clinical Diabetologists (Associazione Medici Diabetologi, AMD) initiative constitutes the study population. Urinary albumin excretion (ACR) and estimated GFR (eGFR) were retrieved and analyzed. The incidence of stage ≥3 CKD (eGFR < 60 mL/min/1.73 m2) or eGFR reduction > 30% from baseline was evaluated. RESULTS: The mean estimated GFR was 98 ± 17 mL/min/1.73m(2) and the proportion of patients with albuminuria was 15.3% (n = 654) at baseline. About 8% (n = 337) of patients developed one of the two renal endpoints during the 4-year follow-up period. Age, albuminuria (micro or macro) and baseline eGFR < 90 ml/min/m(2) were independent risk factors for stage ≥3 CKD and renal function worsening. When compared to patients with eGFR > 90 ml/min/1.73m(2) and normoalbuminuria, those with albuminuria at baseline had a 1.69 greater risk of reaching stage 3 CKD, while patients with mild eGFR reduction (i.e. eGFR between 90 and 60 mL/min/1.73 m2) show a 3.81 greater risk that rose to 8.24 for those patients with albuminuria and mild eGFR reduction at baseline. CONCLUSIONS: Albuminuria and eGFR reduction represent independent risk factors for incident stage ≥3 CKD in T1DM patients. The simultaneous occurrence of reduced eGFR and albuminuria have a synergistic effect on renal function worsening. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1186/s12882-018-1136-6) contains supplementary material, which is available to authorized users. BioMed Central 2018-12-04 /pmc/articles/PMC6280443/ /pubmed/30514308 http://dx.doi.org/10.1186/s12882-018-1136-6 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Mirijello, Antonio
Viazzi, Francesca
Fioretto, Paola
Giorda, Carlo
Ceriello, Antonio
Russo, Giuspina T.
Guida, Pietro
Pontremoli, Roberto
De Cosmo, Salvatore
Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
title Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
title_full Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
title_fullStr Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
title_full_unstemmed Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
title_short Association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
title_sort association of kidney disease measures with risk of renal function worsening in patients with type 1 diabetes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6280443/
https://www.ncbi.nlm.nih.gov/pubmed/30514308
http://dx.doi.org/10.1186/s12882-018-1136-6
work_keys_str_mv AT mirijelloantonio associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT viazzifrancesca associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT fiorettopaola associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT giordacarlo associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT cerielloantonio associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT russogiuspinat associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT guidapietro associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT pontremoliroberto associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT decosmosalvatore associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes
AT associationofkidneydiseasemeasureswithriskofrenalfunctionworseninginpatientswithtype1diabetes